Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Regeneron sinks as Phase 3 skin cancer treatment trial fails

The company faces a wave of price target cuts and a steep stock decline following the late-stage clinical trial failure of its experimental melanoma combination therapy.

Helena Cheng
Author: Helena Cheng

Source: Sherwood News.

Written by

Helena Cheng

in

Business
←House Democrats accuse Trump of ‘corruption unparalleled’ over IRS settlement talks
Jafar Panahi Summoned For Court Hearing In Iran On May 20→

More posts

  • Wes Streeting calls Putin a ‘cold-blooded killer’ as he meets Zelensky in Kyiv

  • Just 22 Times Alexander Skarsgård Served Really, Really Interesting Looks The World Didn’t See Coming

  • Just 22 Times Alexander Skarsgård Served Really, Really Interesting Looks The World Didn’t See Coming

  • Rugby union: England run up record win over New Zealand

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube